KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Raw Materials (2016 - 2018)

Biogen has reported Raw Materials over the past 9 years, most recently at $196.3 million for Q4 2018.

  • For Q4 2018, Raw Materials rose 20.87% year-over-year to $196.3 million; the TTM value through Dec 2018 reached $196.3 million, up 20.87%, while the annual FY2018 figure was $196.3 million, 20.87% up from the prior year.
  • Raw Materials for Q4 2018 was $196.3 million at Biogen, up from $162.4 million in the prior quarter.
  • Over five years, Raw Materials peaked at $213.0 million in Q4 2015 and troughed at $128.3 million in Q4 2014.
  • A 5-year average of $174.1 million and a median of $170.4 million in 2016 define the central range for Raw Materials.
  • Biggest five-year swings in Raw Materials: skyrocketed 66.02% in 2015 and later decreased 20.0% in 2016.
  • Year by year, Raw Materials stood at $128.3 million in 2014, then skyrocketed by 66.02% to $213.0 million in 2015, then fell by 20.0% to $170.4 million in 2016, then dropped by 4.69% to $162.4 million in 2017, then grew by 20.87% to $196.3 million in 2018.
  • Business Quant data shows Raw Materials for BIIB at $196.3 million in Q4 2018, $162.4 million in Q4 2017, and $170.4 million in Q4 2016.